Resources

59 Resources for

david p. hamilton

Subscribe to this listing via:
RSS
Email

BNET Author Biography: David P. Hamilton, a 14-year veteran of the Wall Street Journal, is a freelancebusiness and medical writer in San Francisco. He most recently founded theLifeScience section of VentureBeat, a news site for innovation and venturebusiness. Previously, David covered biotechnology, the Internet, and computingand served as a Tokyo foreign correspondent...; more about David P. Hamilton »

BNET Resources

The Big Bad CEO of Big Coal: Over at BNET's Corner Office blog, Peter Galuszka profiles Donald Blankenship, CEO of Massey Energy, the number four coal producer in the U.S. Dubbing Blankenship "the kind of executive liberal elites love to hate," Galuszka notes his history of dubious environmental practices, browbeating unions, and shutting the press...; Tags: ABC Inc., CEO, Blogging, Internet, David P. Hamilton; Blog posts 2008-05-13
The Cyborg Industry Springs a Squeak: Medical devices are kind of the Rodney Dangerfield of medicine's high-tech armamentarium. Sure, companies like Medtronic, Guidant and Stryker make artificial replacements or supplements for body parts ranging from hearts to bones (OK -- joints), but for whatever reason, devices don't seem to inspire the popular imagination the way, say,...; Tags: Joint, Stryker Corp., NYT, Corporate Communications, Marketing, David P. Hamilton; Blog posts 2008-05-13
The Week That Was in Healthcare: As we start a new week, here's a quick wrapup of important healthcare stories that you might have missed in the week that was: Retail health clinics -- often staffed by non-physicians and set up in big-box retailers or drugstores -- have been touted as one way...; Tags: Program, Patient, Hospital, Health Care, Healthcare, Vertical Industries, Benefits, Data Mining, Enterprise Software, Software, Human Resources, Data Management, David P. Hamilton; Blog posts 2008-05-12
The Week That Was in Pharma: Welcome back from the weekend. Here's a quick roundup of stories you may have overlooked over the past week: Merck said it would cut 1,200 jobs following the FDA's rejection of one cholesterol drug and a scandal that's cuts sales of its combination drug Vytorin, which it...; Tags: FDA, Drug, Observers, Federal Government, Government, David P. Hamilton; Blog posts 2008-05-12
FDA Loosens Rules for Overseas Drug Trials: Merrill Goozner, a former Chicago Tribune reporter turned public-health advocate (he heads up the Integrity in Science Project at the Center for Science in the Public Interest), notes an interesting and almost wholly overlooked Food and Drug Administration decision that may have the effect of subjecting clinical-trial volunteers in poor...; Tags: FDA, Drug, Gist, Federal Government, Government, David P. Hamilton; Blog posts 2008-05-08

Aetna's Ron Williams Speaks -- And Actually Says Something: This Fortune interview with Aetna CEO Ron Williams is a few days old, but as it just popped up in my RSS reader, it is, as they say, new to me. Since it's pretty rare to see someone like Williams candidly discuss the health-plan business, its problems and some intriguing...; Tags: Physician, Decision Support, Aetna Inc., Health Care, Dermatologist, Vertical Industries, Benefits, Healthcare, Enterprise Software, Software, Human Resources, David P. Hamilton; Blog posts 2008-05-08
Schering-Plough Now in the Feds' Crosshairs: The Vytorin scandal just got serious. Well, heck, it was already serious. Make this really serious: Investigation and Inquiries. Through the date of filing this 10-Q, Schering-Plough, the joint venture and/or its ...; Tags: SEC, Merck & Co. Inc., Schering-Plough Corp., Attorney, Vytorin, Sales Strategy, Healthcare, Sales Force Management, Sales, David P. Hamilton; Blog posts 2008-05-07
As Hospitals Hit the Skids, Odds of a Healthcare Crisis Rise: It's not just big insurers who are sinking into the swamp these days -- hospitals are slipping as well. And while it's a little early to know for sure, the problems of health plans seem quite likely to make those of hospitals even worse. Yesterday, Tenet Healthcare...; Tags: Patient, Hospital, Tenet Healthcare Corp., Health Care, Nothing, Healthcare, Vertical Industries, Benefits, Enterprise Software, Software, Human Resources, David P. Hamilton; Blog posts 2008-05-07
Emergent's Vaccine Play: Biotech Can Flip-Flop, Too: For sudden twists of fate, abrupt collapses and the occasional stunning revival, it's hard to beat the biotech industry. Yesterday, for instance, the all-but-dead biotech VaxGen agreed to sell off its ailing anthrax vaccine to its East Coast rival Emergent BioSolutions --a company that spent much of this decade trying...; Tags: Biotechnology, Vaccine, Emergent Biosolutions, VaxGen, Healthcare, David P. Hamilton; Blog posts 2008-05-06
Good News Not Totally Absent in Healthcare: Medical costs continue to rise much faster than general inflation, the insurance safety net is fraying as health plans and hospitals push the financial burden of being ill back onto the sick themselves, and even people who get their insurance through work have seen their premium contributions rise ten times...; Tags: Hospital, Aetna Inc., Health Care, Healthcare, Vertical Industries, Benefits, Enterprise Software, Software, Human Resources, David P. Hamilton; Blog posts 2008-05-06
Man Bites Dog: Former Merck CEO Blasts High Drug Prices: Most pharmaceutical companies insist that high drug prices are a natural consequence of the risky business of drug discovery, and that huge profits on marketed drugs are necessary to cover the costs of the 5,000 to 10,000 experimental drugs that fail for every one that succeeds. In fact, there are...; Tags: Industry, Dr., Merck & Co. Inc., Pharmaceutical Company, Drug, Pricing, Strategy, Marketing, Management, David P. Hamilton; Blog posts 2008-05-05
Life Without Blockbusters: What Valeant's Woes Portend for Pharma: It's now a truism that the drug industry's "blockbuster model" has pretty much had its day. Much of Big Pharma is having a terrible time winning approval for new drugs and even keeping up sales of existing blockbusters, in part because their underlying rationale -- that pushing drugs into mass...; Tags: Pharmaceutical Company, Blockbuster, Drug, Valeant, David P. Hamilton; Blog posts 2008-05-05
Michigan Nukes Expensive Cancer-Radiation Sites: When a Michigan commission recently voted to deny several hospitals the right to build expensive "proton-beam therapy" sites for cancer treatment, it took a major step into the brave new world of explicit healthcare rationing. The rationale behind the decision was fairly straightforward. Four hospitals had each...; Tags: Hospital, Center, Healthcare, David P. Hamilton; Blog posts 2008-05-05
Esperion Escapes the Pfizer Borg: Esperion Therapeutics, a biotech that Pfizer spent $1.3 billion acquiring in 2003, is free once more. And its founder, Roger Newton, is apparently putting the band back together. Newton, in fact, has just pulled off one of the rarer and most complicated moves in biotechnology -- the...; Tags: Pfizer Inc., Esperion, Biotechnology, Mergers & Acquisitions, Investment, Finance, David P. Hamilton; Blog posts 2008-05-01
Pharmacies Push the E-Prescribing Boulder Uphill: If you flog it, they will come. Or so ten major pharmacy chains seem to think, since they've just launched a national marketing campaign aimed at raising "consumer awareness" about electronic prescriptions, or e-prescribing (free registration required). The logic behind electronic prescriptions is much the same --...; Tags: Pharmacy, Prescription, E-health, Government, Healthcare, Fax, Marketing Research, Marketing, David P. Hamilton; Blog posts 2008-05-01
Are Half of Hospitals Insolvent? Not Exactly: A few weeks ago, we highlighted the surprising fact that top nonprofit hospitals in the U.S. are making a ton of money, even as many of them shirk their legal duty to serve the uninsured. Some are now even charging patients enormous sums up front before treating them for cancer...; Tags: Hospital, Healthcare, David P. Hamilton; Blog posts 2008-04-30
Congress Might Mandate a Federal Drug-Tracking System: Over the past few years, a rise in counterfeit versions of name-brand drugs has generated a fair amount of concern within government and the drug industry. (The growing scandal over tainted heparin, while a separate issue, hasn't helped.) And yet drugmakers have balked at current plans to track genuine drugs...; Tags: Industry, U.S. Congress, Pharmaceutical Company, David P. Hamilton; Blog posts 2008-04-30
Electronic Medical Records: Bad for Health?: Electronic medical records could let patients travel freely to doctors of their choice, improve their odds of getting the right care in emergencies and reduce medical errors, duplicated tests and unnecessary prescriptions. They're also the standard in most industrialized nations as well as U.S. healthcare systems such as the Cleveland...; Tags: Electronic Record, Patient, Physician, Electronic Health Record, Health Care, David P. Hamilton; Blog posts 2008-04-29
FDA to New Drugs: It's Hammer Time: Wonder no further whether the recent litany of drug-safety problems would make the Food and Drug Administration more cautious about approving new drugs. In just the past four days, the agency has thrown some serious sand into the industry's drug-development works, delaying or derailing three separate programs of widely varying...; Tags: FDA, Agency, Merck & Co. Inc., Cordaptive, Federal Government, Government, David P. Hamilton; Blog posts 2008-04-29
Cash Up Front or Else -- Why Hospitals Are Gouging Their Patients: People who've just been diagnosed with a life-threatening disease already have plenty of things to worry about. Now comes one more unexpected concern: Many large hospitals are demanding up-front payment before they'll admit patients for cancer treatment and other expensive care. This WSJ story is a classic...; Tags: Payment, Patient, Hospital, Insurance Company, Health Care, Insurance, Healthcare, David P. Hamilton; Blog posts 2008-04-28